COVID deaths dropped precipitously—by 14-fold—in the regions where the Peruvian government effectively distributed ivermectin. Reductions in deaths correlated with the extent of IVM distributions in all 25 states. In December 2020, Peru’s new president, under pressure from WHO, severely restricted IVM availability and COVID cases rebounded with deaths increasing 13-fold.